140 related articles for article (PubMed ID: 2925625)
1. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
3. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
Chae K; Johnston SH; Korach KS
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor stereochemistry: receptor binding and hormonal responses.
Korach KS; Levy LA; Sarver PJ
J Steroid Biochem; 1987; 27(1-3):281-90. PubMed ID: 3695485
[TBL] [Abstract][Full Text] [Related]
5. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness.
Korach KS; Chae K; Gibson M; Curtis S
Steroids; 1991 May; 56(5):263-70. PubMed ID: 1877066
[TBL] [Abstract][Full Text] [Related]
7. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses.
Korach KS; Fox-Davies C; Quarmby VE; Swaisgood MH
J Biol Chem; 1985 Dec; 260(29):15420-6. PubMed ID: 4066677
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
[TBL] [Abstract][Full Text] [Related]
9. Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists.
Curtis SW; Shi H; Teng C; Korach KS
J Mol Endocrinol; 1997 Jun; 18(3):203-11. PubMed ID: 9195474
[TBL] [Abstract][Full Text] [Related]
10. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
11. Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule polymerization.
Oda T; Sakakibara Y; Sato Y; Hanzawa H; Hata T
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):588-92. PubMed ID: 1611675
[TBL] [Abstract][Full Text] [Related]
12. Diethylstilbestrol metabolites and analogs. New probes for the study of hormone action.
Korach KS; Metzler M; McLachlan JA
J Biol Chem; 1979 Sep; 254(18):8963-8. PubMed ID: 479173
[No Abstract] [Full Text] [Related]
13. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
Sato B; Spomer W; Huseby RA; Samuels LT
Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
15. Estrogen dependent induction of low affinity binding sites in the nuclear fraction of rat uterus.
De Hertogh R; Ekka E; Vanderheyden I
J Steroid Biochem; 1986 Jun; 24(6):1171-7. PubMed ID: 3736044
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor residues required for stereospecific ligand recognition and activation.
Bocchinfuso WP; Korach KS
Mol Endocrinol; 1997 May; 11(5):587-94. PubMed ID: 9139802
[TBL] [Abstract][Full Text] [Related]
17. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs.
Korach KS; Metzler M; McLachlan JA
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):468-71. PubMed ID: 272664
[TBL] [Abstract][Full Text] [Related]
19. The relative binding affinity of diethylstilbestrol to uterine nuclear estrogen receptor: effect of serum and serum albumin.
Okulicz WC; Johnson LD
Proc Soc Exp Biol Med; 1987 Sep; 185(4):478-83. PubMed ID: 3615411
[TBL] [Abstract][Full Text] [Related]
20. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
